BASKING RIDGE, N.J.--(BUSINESS WIRE)--March 14, 2006--Over 400 New Oncology Patients Begin Using Resurgex(R) Products Within the First 120 days of Introduction to Oncology Sector. In the past 120 days of Millennium’s National product launch in the oncology sector, the sales effort has yielded over 400 new patients who are now using Resurgex(R) as an adjunct to their cancer treatment. The majority of these patients are receiving their treatment in major cancer institutions around the country. Most of the patients are exposed to the product through the Resurgex Taste and Learning Centers (TLC), which are strategically placed in waiting rooms and or infusion rooms in major cancer institutions nationwide. The TLC’s allow the patients to sample a variety of Resurgex products while providing them with important educational and purchasing information about the product line.
